Clinical Trials Browser

Withdrawn × Interventional × B3(Fv)-PE38KDEL recombinant immunotoxin × Clear all

NCT00389506 2012-03-16

Fludarabine and Cyclophosphamide Followed By LMB-2 Immunotoxin in Treating Patients With Hodgkin's Lymphoma

Phase NA Withdrawn

Hodgkin Disease, Lymphoma